NexGel, Inc. (NXGL)
0.174
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.1664
-0.01
(-4.37%)
After-Hours: 20:00
NexGel Debt to Equity Ratio : 1.507 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.507 |
| March 31, 2026 | 1.073 |
| December 31, 2025 | 0.6925 |
| September 30, 2025 | 0.6155 |
| June 30, 2025 | 0.5684 |
| March 31, 2025 | 0.5264 |
| December 31, 2024 | 0.4911 |
| September 30, 2024 | 0.6951 |
| June 30, 2024 | 0.7187 |
| March 31, 2024 | 0.6416 |
| December 31, 2023 | 0.5957 |
| September 30, 2023 | 0.4168 |
| June 30, 2023 | 0.3771 |
| March 31, 2023 | 0.3472 |
| December 31, 2022 | 0.2728 |
| September 30, 2022 | 0.2582 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.3634 |
| March 31, 2022 | 0.2996 |
| December 31, 2021 | 0.3528 |
| September 30, 2021 | 7.337 |
| June 30, 2021 | 10.91 |
| March 31, 2021 | 1.408 |
| December 31, 2020 | 17.99 |
| September 30, 2020 | 3.329 |
| June 30, 2020 | 2.878 |
| March 31, 2020 | 1.601 |
| December 31, 2019 | 2.413 |
| September 30, 2019 | 5.016 |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IDEXX Laboratories, Inc. | 0.6797 |
| Neogen Corp. | 0.388 |
| QuidelOrtho Corp. | 1.733 |
| Aspira Women's Health, Inc. | -0.4279 |
| Biomerica, Inc. | 0.9061 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 26.45M |
| Total Liabilities (Quarterly) | 20.98M |
| Shareholders Equity (Quarterly) | 4.949M |
| Current Ratio | 0.4273 |
| Net Debt Paydown Yield | -19.41% |